• ICH GCP
    • Dansk
    • Deutsch
    • English
    • Español
    • Français
    • Italiano
    • Magyar
    • Nederlands
    • Norsk
    • Polski
    • Português
    • Suomi
    • Svenska
    • Čeština
    • Русский
    • 日本語
    • 简体中文
    • 한국어
  • Regulations
    • USA (FDA)
    • UK (MHRA)
    • AUSTRALIA (NHMRC)
    • JAPAN (PMDA)
  • CRO List
  • Clinical Trials
    • US Clinical Trials Registry
    • EU Clinical Trials Registry
    • Pharmaceutical Companies
    • Clinical Research Labs
    • Clinical Research Events
    • Publications
    • Researchers
  • Jobs
  • Publications
  • News
  • Regulations
    • GLOBAL (ICH GCP)
    • USA (FDA)
    • UK (MHRA)
    • AUSTRALIA (NHMRC)
    • JAPAN (PMDA)
    • EU (EMA)
  • CRO List
  • Clinical Trials
    • US Clinical Trials Registry
    • EU Clinical Trials Registry
    • Pharmaceutical Companies
    • Clinical Research Labs
    • Service Companies
    • Clinical Research Events
    • Publications
    • Researchers
  • Jobs
  • Publications
  • News
Example: Heart Attack
  • Glossary
  • Understanding Clinical Trials

Search clinical trials for: First Line Therapy

Total 10000 results


  • NCT00931463
    Completed
    A Trial of 2 Options for Second Line Combination Antiretroviral Therapy Following Virological Failure of a Standard Non-nucleoside Reverse Transcriptase Inhibitor (NNRTI)+2N(t)RTI First Line Regimen (SECOND-LINE)
    HIV Infections
  • NCT01803438
    Completed
    Catheter Cryoablation Versus Antiarrhythmic Drug as First-Line Therapy of Paroxysmal Atrial Fibrillation
    Symptomatic Paroxysmal Atrial Fibrillation Without Clinically Significant Heart Diseases
  • NCT03728374
    Unknown
    Anlotinib Hydrochloride as Second-line Therapy in Elderly Patients With EGFR Wild-type Lung Adenocarcinoma
    Non-Small-Cell Lung Cancer
  • NCT07822542
    Not yet recruiting
    A Study Evaluating HS-10370 Plus Platinum-based Doublet Chemotherapy With or Without Adebrelimab vs. Tislelizumab Plus Chemotherapy as First-Line Therapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
    Carcinoma, Non-Small-Cell Lung
  • NCT07817654
    Not yet recruiting
    Trastuzumab Combined With Retlirafusp Alfa in Treating HER2(Human Epidermal Growth Factor Receptor 2) 2+/3+ Gastric/Gastroesophageal Junction Adenocarcinoma After First-line Systemic Therapy Failure
    GC | GEJC

This is a preview
Log in or create a free account to see all matching trials and use the full search.
Log in | Register

Cookie Settings

We use cookies to ensure that we give you the best experience on our website. For more details carefully read our Privacy and Cookies Policy. ...>>>You can change your preferences or withdraw your consent at any time by deleting the cookies from your website or computer as described in the policy. Please accept it and choose your preferences by ticking the corresponding boxes in the "Manage Settings" section below. Please carefully read our Terms of Service before you proceed with using any part of this website.

«Manage Settings
Regulations
  • GLOBAL (ICH GCP)
  • USA (FDA)
  • UK (MHRA)
  • AUSTRALIA (NHMRC)
  • JAPAN (PMDA)
  • EU (EMA)
Resources
  • CRO List
  • Pharmaceutical Companies
  • Clinical Research Labs
  • Service Companies
  • Jobs
  • US Clinical Trials Registry
  • EU Clinical Trials Registry
Articles
  • Publications
  • News
  • About us / Our mission
Language
Dansk Deutsch English Español Français Italiano Magyar Nederlands Norsk Polski Português Suomi Svenska Čeština Русский 日本語 简体中文 한국어
  • Sitemap
  • Contact us
  • RSS feed
  • Privacy Policy
  • Disclaimer
© ICH GCP. All Rights Reserved.